Mr. Stout was nominated for The Health Care Leadership Awards by the Los Angeles Business Journal in 2023, and was named one of the 20 Most Influential Healthcare Entrepreneurs to watch in 2021.
LOS ANGELES, CA, June 13, 2024 /24-7PressRelease/ -- Scott Stout has been selected for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
As the Chief Executive Officer and Co-Founder of MedVector Clinical Trials, Mr. Stout aims to enable "clinical trials as a care option," transforming how people access advanced medicine. His goal; to make advanced medicines more affordable and equitable, regardless of geographic location or socioeconomic status. He plays an instrumental role in steering the company's strategic direction and message, while acting as a thought leader for industry and frequently speaking at conferences and other public forums. A quick web search reveals notable publications and speaking engagements across the United States.
Prior to founding MedVector, Mr. Stout was passionate about helping startups using his financial background. His career in finance included roles as a Financial Advisor and Options Strategist with Wells Fargo Private Bank, Morgan Stanley, and D&S Investments ranging from 2008 to 2018. In his twenties, before finance, his work could be found on the occasional billboard, magazine, or television commercial working as an actor/model. Throughout his career, Mr. Stout has demonstrated exceptional skill in investing, raising capital, capturing audience attention, and articulating difficult concepts effectively.
Mr. Stout recognized the importance of advanced medicine after experiencing an illness in his early thirties that prevented him from walking. The illness was difficult to diagnose until he met a clinical research physician who suggested an advanced medicine. Within hours, Mr. Stout was back to walking, and within weeks, back to his normal life which included golfing, skiing, rock-climbing, and motorcycling. As a result, the seed was planted to make advanced medications more easily available and affordable to the people that need them.
Mr. Stout's academic background includes a Bachelor of Science in Marketing from the University of Arizona, where he graduated in 2002. His education has played a pivotal role in his professional achievements, providing him with a solid foundation in business principles and strategic thinking. Mr. Stout attributes his success to always "swimming downstream" while being ready to seize new opportunities.
Along with his professional endeavors, his innovative work in healthcare has been recognized by several awards and nominations. Mr. Stout was nominated for The Health Care Leadership Awards by the Los Angeles Business Journal in 2023, and was named one of the 20 Most Influential Healthcare Entrepreneurs to watch in 2021. Mr. Stout's thought leadership is also evident through his appearances on platforms such as The Health Care Insights, Note to File, and The Clinical Trial Guru.
In addition to devoting time to his 3 boys, Mr. Stout envisions taking MedVector public within the next decade to maximize investor returns and further contribute to making the pharmaceutical industry more patient-centric and innovative.
About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.
# # #